Estudo clínico para validação da eficácia de pomada contendo barbatimão (Stryphnodendron adstringens (Mart.) Coville)* na cicatrização de úlceras de decúbito / Clinical study for the validation of the efficacy of ointment containing barbatimao (Stryphnodendron adstringens (Mart.) Coville)* on healing of decubitus ulcers

O extrato aquoso de Stryphnodendron adstringens é tradicionalmente utilizado no Brasil como cicatrizante. Estudo clínico conduzido por seis meses teve por objetivo avaliar a eficácia de um medicamento na forma de pomada, contendo 3% de fitocomplexo fenólico de barbatimão na cicatrização de úlceras de decúbito. Foram submetidos ao protocolo clínico 27 pacientes apresentando um total de 51 úlceras, classificadas de acordo com a área e grau de profundidade (I a III) da lesão. Em média a cicatrização das lesões de grau I e II ocorreu num período de 3 a 6 semanas e as de grau III entre 10 e 18 semanas. Durante a realização do estudo 100% das lesões tratadas com o medicamento cicatrizaram completamente.

Anti-inflammatory and anti-nociceptive effects of Zeyheria montana (Bignoniaceae) ethanol extract

In this work, the analgesic and anti-inflammatory activities of Zeyheria montana Mart. ethanol leaf extract were investigated at doses of 75, 150 and 300 mg/kg body weight. In the analgesic assay, against a chemical stimulus in mice, acetic acid-induced writhes were significantly inhibited by the extract at doses of 75 mg/kg (67.27 percent), 150 mg/kg (49.38 percent) and 300 mg/kg (82.87 percent). Also, a vigorous decrease in hyperalgesia was observed when measured after 2 h and 6 h of lipopolysaccharide stimulation of rats for all doses of extract tested. Z. montana extract, at doses of 75 and 300 mg/kg, caused very slight central analgesia in rats submitted to thermal stimulus, particularly noticeable at 30 min following treatment. The anti-inflammatory activity of Z. montana extract on carrageenan-induced oedema in rats was evaluated. The oedema development, measured at 180 min following carrageenan intraplantar injection, was significantly reduced by all tested doses: 75 mg/kg (33.30 percent), 150 mg/kg (45.80 percent) and 300 mg/kg (75.00 percent). The LD50 value was greater than 2000 mg/kg. These results demonstrated that the ethanol extract from Z. montana leaf possesses anti-nociceptive and anti-inflammatory activities, which could be of relevance for the pharmacological control of pain and inflammatory processes.